What drove the SKIN.SW stock move on 19 Feb 2026?

SKIN.SW stock rose **9.85%** to **CHF35.70** on higher-than-average volume (**2756.00** vs **1818.00**), likely driven by short-term positioning ahead of pipeline catalysts and dealer rebalancing on the SIX (Switzerland).

What is the Meyka AI view and score for SKIN.SW stock?

Meyka AI rates SKIN.SW with a score out of 100 at **62.48** (Grade B, Suggestion: HOLD). The grade weighs benchmarks, sector and financial metrics; it is informational and not investment advice.

What are the key technical levels for SKIN.SW stock to watch?

Watch the 50-day average **CHF34.37** as near-term support and the 200-day average **CHF37.22** as resistance. A sustained close above **CHF36.00** would signal short-term momentum continuation.

What price targets and forecast exist for SKIN.SW stock?

Meyka AI's forecast model projects **CHF42.00** (12-month), implying **+17.65%** from **CHF35.70**. Conservative downside is **CHF30.00**, bull case **CHF48.00**. Forecasts are model-based projections and not guarantees.

CH Stocks

SKIN.SW stock jumps 9.85% to CHF35.70 on 19 Feb 2026: monitor 50-day support

ByDanny Kontos February 19, 2026

SKIN.SW stock led active trading on the SIX (Switzerland) close on 19 Feb 2026, jumping 9.85% to CHF35.70 on high volume 2756.00 shares. The move pushed the intraday high to CHF36.00 from an open of CHF32.00, and outpaced the average volume of 1818.00. That surge makes SKIN.SW stock a high-volume mover today and puts the 50-day average (CHF34.37) squarely in focus as short-term support for traders and investors weighing the biotech pipeline and valuation.